141 – 150 of 160
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2000
-
Mark
Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds
(
- Contribution to journal › Article
- 1999
-
Mark
Prevalence of β-cell and Thyroid Autoantibody Positivity in Schoolchildren during Three-Year Follow-up
(
- Contribution to journal › Article
-
Mark
Appearance of islet cell autoantibodies after clinical diagnosis of diabetes mellitus
(
- Contribution to journal › Article
-
Mark
Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment : A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes
(
- Contribution to journal › Article
-
Mark
Negative association between type 1 diabetes and HLA DQB1*0602-DQA1*0102 is attenuated with age at onset
(
- Contribution to journal › Article
- 1998
-
Mark
Inverse relationship between GAD65 antibody levels and severe retinopathy in younger type 1 diabetic patients
(
- Contribution to journal › Article
-
Mark
A simple and rapid microSepharose assay for GAD65 and ICA512 autoantibodies in diabetes
(
- Contribution to journal › Article
- 1997
-
Mark
Glutamate decarboxylase antibodies in non-diabetic pregnancy precedes insulin-dependent diabetes in the mother but not necessarily in the offspring
(
- Contribution to journal › Article
- 1996
-
Mark
HLA-DQB1*0201/0302 is associated with severe retinopathy in patients with IDDM
(
- Contribution to journal › Article
-
Mark
Autoimmune (type 1) diabetes in young adults in Sweden
(
- Contribution to journal › Article